Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Established, science-forward copper peptide lines in 2026 include Skin Biology (founded by GHK's discoverer, Loren Pickart), NIOD's Copper Amino Isolate Serum, The Ordinary's copper peptide offering, and several professional and clinical brands such as Biopelle
It is identified in the clinical-research literature under the development designation LY3437943 and is currently in Phase 3 evaluation under the TRIUMPH trial program
This potential appears to be partially mediated through the positive action of GHK-Cu recruitment on fibroblasts, endothelial cells, and immune cells
doi: 10.2337/db10-0474 158 JelsingJVrangNHansenGRaunKTang-ChristensenMKnudsenLB
Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancer
US$ 28.81
US$ 26.80
/assets/images/provider/photos/2798511.png)
US$ 26.82
US$ 22.39
US$ 20.18
US$ 29.38
